Literature DB >> 26765997

Suppressor of cytokine signaling 2 modulates the immune response profile and development of experimental cerebral malaria.

Fatima Brant1, Aline S Miranda1, Lisia Esper1, Melisa Gualdrón-López2, Daniel Cisalpino3, Danielle da Gloria de Souza3, Milene Alvarenga Rachid4, Herbert B Tanowitz5, Mauro Martins Teixeira1, Antônio Lucio Teixeira1, Fabiana Simão Machado6.   

Abstract

Plasmodium falciparum infection results in severe malaria in humans, affecting various organs, including the liver, spleen and brain, and resulting in high morbidity and mortality. The Plasmodium berghei ANKA (PbA) infection in mice closely recapitulates many aspects of human cerebral malaria (CM); thus, this model has been used to investigate the pathogenesis of CM. Suppressor of cytokine signaling 2 (SOCS2), an intracellular protein induced by cytokines and hormones, modulates the immune response, neural development, neurogenesis and neurotrophic pathways. However, the role of SOCS2 during CM remains unknown. SOCS2 knockout (SOCS2(-/-)) mice infected with PbA show an initial resistance to infection with reduced parasitemia and production of TNF, TGF-β, IL-12 and IL-17 in the brain. Interestingly, in the late phase of infection, SOCS2(-/-) mice display increased parasitemia and reduced Treg cell infiltration, associated with enhanced levels of Th1 and Th17 cells and related cytokines IL-17, IL-6, and TGF-β in the brain. A significant reduction in protective neurotrophic factors, such as glial cell line-derived neurotrophic factor (GDNF) and brain-derived neurotrophic factor (BDNF), was also observed. Moreover, the molecular alterations in the brain of infected SOCS2(-/-) mice were associated with anxiety-related behaviors and cognition impairment. Mechanistically, these results revealed enhanced nitric oxide (NO) production in PbA-infected SOCS2(-/-) mice, and the inhibition of NO synthesis through l-NAME led to a marked decrease in survival, the disruption of parasitemia control and more pronounced anxiety-like behavior. Treatment with l-NAME also shifted the levels of Th1, Th7 and Treg cells in the brains of infected SOCS2(-/-) mice to the background levels observed in infected WT, with remarkable exception of increased CD8(+)IFN(+) T cells and inflammatory monocytes. These results indicate that SOCS2 plays a dual role during PbA infection, being detrimental in the control of the parasite replication but crucial in the regulation of the immune response and production of neurotrophic factors. Here, we provided strong evidence of a critical relationship between SOCS2 and NO in the orchestration of the immune response and development of CM during PbA infection.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  BDNF; Cerebral malaria; GDNF; Immune regulation; Neuroimmune response; Neuroinflammation; Neurotrophic factors; Nitric oxide; SOCS2; l-NAME

Mesh:

Substances:

Year:  2016        PMID: 26765997     DOI: 10.1016/j.bbi.2016.01.002

Source DB:  PubMed          Journal:  Brain Behav Immun        ISSN: 0889-1591            Impact factor:   7.217


  7 in total

Review 1.  Genetic analysis of cerebral malaria in the mouse model infected with Plasmodium berghei.

Authors:  Sabrina Torre; David Langlais; Philippe Gros
Journal:  Mamm Genome       Date:  2018-06-19       Impact factor: 2.957

2.  The suppressor of cytokine signalling 2 (SOCS2), traumatic brain injury and microglial/macrophage regulation.

Authors:  Harleen S Basrai; Ann M Turnley
Journal:  Neural Regen Res       Date:  2016-09       Impact factor: 5.135

Review 3.  Pathophysiology and neurologic sequelae of cerebral malaria.

Authors:  Nicoline Schiess; Andres Villabona-Rueda; Karissa E Cottier; Katherine Huether; James Chipeta; Monique F Stins
Journal:  Malar J       Date:  2020-07-23       Impact factor: 2.979

Review 4.  The Rough Guide to Monocytes in Malaria Infection.

Authors:  Amaya Ortega-Pajares; Stephen J Rogerson
Journal:  Front Immunol       Date:  2018-12-07       Impact factor: 7.561

5.  SOCS2 Is Critical for the Balancing of Immune Response and Oxidate Stress Protecting Against Acetaminophen-Induced Acute Liver Injury.

Authors:  Renata Monti-Rocha; Allysson Cramer; Paulo Gaio Leite; Maísa Mota Antunes; Rafaela Vaz Sousa Pereira; Andréia Barroso; Celso M Queiroz-Junior; Bruna Araújo David; Mauro Martins Teixeira; Gustavo Batista Menezes; Fabiana Simão Machado
Journal:  Front Immunol       Date:  2019-01-22       Impact factor: 7.561

6.  SOCS2 Inhibits Mitochondrial Fatty Acid Oxidation via Suppressing LepR/JAK2/AMPK Signaling Pathway in Mouse Adipocytes.

Authors:  Tiantian Zhang; Yizhe Chen; Jiarui Cai; Miao Pan; Qian Sun; Jing Zhang; Chao Sun
Journal:  Oxid Med Cell Longev       Date:  2020-07-13       Impact factor: 6.543

7.  Role of SOCS2 in the Regulation of Immune Response and Development of the Experimental Autoimmune Encephalomyelitis.

Authors:  Allysson Cramer; Bruno Cabral de Lima Oliveira; Paulo Gaio Leite; David Henrique Rodrigues; Fatima Brant; Lisia Esper; Pollyana Maria Oliveira Pimentel; Rafael Machado Rezende; Milene Alvarenga Rachid; Antonio Lucio Teixeira; Ana Maria Caetano Faria; Mauro Martins Teixeira; Fabiana Simão Machado
Journal:  Mediators Inflamm       Date:  2019-12-23       Impact factor: 4.711

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.